The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 27, 2022

Filed:

Sep. 18, 2017
Applicant:

Lcb Pharma Inc., Montréal, CA;

Inventors:

Yvan Guindon, Montréal, CA;

Philippe Mochirian, Montréal, CA;

Mona Nemer, Ottawa, CA;

Michel Prévost, Montréal, CA;

Assignee:

LCB Pharma Inc., Montreal, CA;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07H 19/10 (2006.01); C07H 19/20 (2006.01); C07H 19/23 (2006.01); A61P 31/12 (2006.01); A61P 35/00 (2006.01); A61P 9/00 (2006.01);
U.S. Cl.
CPC ...
C07H 19/10 (2013.01); A61P 9/00 (2018.01); A61P 31/12 (2018.01); A61P 35/00 (2018.01); C07H 19/20 (2013.01); C07H 19/23 (2013.01);
Abstract

The compounds are nucleoside and nucleotide analogues that can be used as anticancer or antiviral agents. The compounds include tetrahydrofuranyl or tetrahydrothienyl moieties with quaternary stereogenic all-carbon center at the 3' position and bear a phosphoryl group at either one of, or both of positions C5′ and/or C3′; have a quaternary stereogenic all-carbon center at one of the 3′ position, 2′ position, or no quaternary stereogenic center at all, and bear a β-blocked lipoate derivative attached through an amide bond to the primary amine of the nucleobase; or have a quaternary stereogenic all-carbon center at the 2′ position and bear a phosphorylated prodrug at the C5′-position and a β-blocked lipoate derivative attached through an amide bond to the primary amine of the nucleobase


Find Patent Forward Citations

Loading…